
Opinion|Videos|April 1, 2024
Key Takeaways Regarding Operationalizing Bispecific Antibodies for MM
Panelists summarize key takeaways on using bispecific antibodies for multiple myeloma treatment.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Phase 3 Trial Marks First Success for Personalized mRNA Cancer Therapy in Resected Melanoma
2
New Hypertension Guideline: Key Shifts for Pharmacists
3
FDA Approves Garetosmab-grts, First Treatment for FOP Bone Growth
4
The Main Street Pharmacy Access Act: A Small Bill Asking a Big Question
5






































































































